Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL

Authors:

Abstract
No abstract available
Funding Information
  • DHHS (R43CA177067)
  • National Cancer Institute
  • DHHS (P30CA014089, U01-CA-151837, R01CA-154471, R21-CA-164098)
  • National Cancer Institute
  • V-Foundation
  • Nautica Triathlon
  • Ronald McDonald House Charities of Southern California
  • NSF-CHE (1308485)
  • NIH (1DP2OD007246)

This publication has 25 references indexed in Scilit: